HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EWG pushing again for final sunscreen monograph

This article was originally published in The Rose Sheet

Executive Summary

FDA should make haste - before summer - to issue enforceable sunscreen standards that include requirements for ultraviolet-A (UVA) protection, according to April 2 letter from the Environmental Working Group. Addressed to FDA's Center for Drug Evaluation and Research Director Janet Woodcock, the letter encourages the agency to complete its health and safety reviews of new active ingredients awaiting approval so that sunscreen formulators in the U.S. can move forward with "safer" sunscreens. EWG cites the fact that while 29 ultraviolet filters have been approved in the EU, only 17 have gotten the nod in the U.S. FDA has said it is aiming to release the final OTC sunscreen monograph in May (1"The Rose Sheet" March 22, 2010). An amended final version of the rule was released in 2007, but has been met with criticism from industry

You may also be interested in...

With Summer In Sight, FDA Pushes Final Sunscreen Rule To Fall

FDA aims to issue a final OTC monograph for sunscreens in October, according to the Department of Health and Human Services' semi-annual regulatory agenda published April 26

FDA re-targets final sunscreen rule for May

According to Department of Health and Human Services' Dec. 7 semi-annual agenda, FDA aims to publish a final monograph for OTC sunscreen products in May. The agency has missed its target before, shooting for September in its summer 2009 agenda (1"The Rose Sheet" June 1, 2009). The final version of the monograph - which would address requirements for UVA protection - initially emerged in 1999 but has been consistently delayed. "FDA believes it is important to public health that we issue a final rule for OTC sunscreens as soon as possible," an FDA spokeswoman wrote in a March 17 e-mail to "The Rose Sheet." The agency is likely to take fire if another summer passes without formal protection standards for sunscreen manufacturers (2"The Rose Sheet" Nov. 24, 2008, In Brief)

Sanofi Bets Big On IO With Synthorx Buy

The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts